Identification of mitochondrial F1 F0-ATP synthase interacting with galectin-3 in colon cancer cells

Cancer Science

Volumn 99, Issue 10, 2008, Pages 1884-1891

  Kim, Duck Woo ^a   Kim, Kyung Hee ^b   Yoo, Byong Chul ^b   Hong, Sung Hye ^b,c   Lim, Yong Chul ^d   Shin, Young Kyoung ^c   Park, Jae Gahb ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GALECTIN 3; MITOCHONDRIAL ENZYME; NOCODAZOLE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VALIDATION PROCESS;

CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; GALECTIN 3; HUMANS; INTRACELLULAR MEMBRANES; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; REPRODUCIBILITY OF RESULTS;

EID: 54949120596     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00901.x     Document Type: Article

References (33)

1. Barondes SH, Castronovo V, Cooper DN et al. Galectins: A family of animal β-galactoside-binding lectins. Cell 1994; 76: 597-8.
2. Dumic J, Dabelic S, Flogel M. Galectin-3: An open-ended story. Biochimica et Biophysica Acta 2006; 1760: 616-35.
3. Ruebel KH, Jin L, Qian X et al. Effects of DNA methylation on galectin-3 expression in pituitary tumors. Cancer Res 2005; 65: 1136-40.
4. Paz A, Haklai R, Elad-Sfadia G et al. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 2001; 20: 7486-93.
5. Takenaka Y, Fukumori T, Yoshii T et al. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 2004; 24: 4395-406.
6. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002; 1572: 263-73.
7. Takenaka Y, Fukumori T, Raz A. Galectin-3 and metastasis. Glycoconj J 2004; 19: 543-9.
8. Liu FT, Rabinovich G. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29-41.
9. Choi JH, Chun KH, Raz A et al. Inhibition of N-(4-hydroxyphenyl) retinamide-induced apoptosis in breast cancer cells by galectin-3. Cancer Biol Ther 2004; 3: 447-52.
10. Hoyer KK, Pang M, Gui D et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol 2004; 164: 893-902.
11. Nakahara S, Oka N, Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis 2005; 10: 267-75.
12. Sanjuan X, Fernandez PL, Castells A et al. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 1997; 113: 1906-15.
13. Honjo Y, Inohara H, Akahani S et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 2000; 6: 4635-40.
14. van den Brule FA, Waltregny D, Liu FT et al. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 2000; 89: 361-7.
15. Castronovo V, Campo E, van den Brule FA et al. Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst 1992; 84: 1161-9.
16. Lotz MM, Andrews CW, Korzelius CA et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 1993; 90: 3466-70.
17. Irimura T, Matsushita Y, Sutton RC et al. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991; 51: 387-93.
18. Schoeppner HL, Raz A, Ho SB et al. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 1995; 75: 2818-26.
19. Nagy N, Legendre H, Engels O et al. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin finger-printing. Cancer 2003; 97: 1849-58.
20. Shin YK, Yoo BC, Chang HJ et al. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 2005; 15: 3162-70.
21. Pedersen PL, Hullihen J. Adenosine triphosphatase of rat liver mitochondria. Capacity of the homogeneous F1 component of the enzyme to restore ATP synthesis in urea-treated membranes. J Biol Chem 1978; 253: 2176-83.
22. McEnery MW, Buhle EL Jr, Aebi U et al. Proton ATPase of rat liver mitochondria. Preparation and visualization of a functional complex using the novel zwitterionic detergent 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate. J Biol Chem 1984; 259: 4642-51.
23. Papa S, Zanotti F, Cocco T et al. Identification of functional domains and critical residues in the adenosinetriphosphatase inhibitor protein of mitochondrial F0F1 ATP synthase. Eur J Biochem 1996; 240: 461-7.
24. Krzeslak A, Lipinska A. Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 2004; 9: 305-28.
25. Matarrese P, Tinari N, Semeraro ML et al. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 2000; 473: 311-15.
26. Moon BK, Lee YJ, Battle P et al. Galectin-3 protects human breast carcinoma cells against nitric oxide induced apoptosis. Implication of galectin-3 function during metastasis. Am J Pathol 2001; 159: 1055-60.
27. Yu F, Finley RL, Raz A et al. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 2002; 277: 15.819-27.
28. Collinson IR, Runswick MJ, Buchanan SK et al. F0 membrane domain of ATP synthase from bovine heart mitochondria: Purification, subunit composition, and reconstitution with F1-ATPase. Biochemistry 1994; 33: 7971-8.
29. Chang HJ, Lee MR, Hong SH et al. Identification of mitochondrial F0F1-ATP synthase involved in liver metastasis of colorectal cancer. Cancer Sci 2007; 98: 1184-91.
30. Champagne E, Martinez LO, Collet X et al. Ecto-F1F0 ATP synthase/F1 ATPase: Metabolic and immunological functions. Curr Opin Lipidol 2006; 17: 279-84.
31. Das AM. Regulation of the mitochondrial ATP-synthase in health and disease. Mol Genet Metab 2003; 79: 71-82.
32. Kim HR, Lin HM, Biliran H et al. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 1999; 59: 4148-54.
33. 2/M arrest and inhibits apoptosis. Carcinogenesis 2000; 21: 1941-5.